Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Rheumatoid arthritis (RA) is a painful, chronic disorder and there is currently an unmet need for effective therapies that will benefit a wide range of patients. The research and development process for therapies and treatments currently involves in vivo studies, which have the potential to cause discomfort, pain or distress. This Working Group report focuses on identifying causes of suffering within commonly used mouse and rat 'models' of RA, describing practical refinements to help reduce suffering and improve welfare without compromising the scientific objectives. The report also discusses other, relevant topics including identifying and minimising sources of variation within in vivo RA studies, the potential to provide pain relief including analgesia, welfare assessment, humane endpoints, reporting standards and the potential to replace animals in RA research.

Original publication

DOI

10.1007/s10787-015-0241-4

Type

Journal article

Journal

Inflammopharmacology

Publication Date

08/2015

Volume

23

Pages

131 - 150

Keywords

Animal Testing Alternatives, Animal Welfare, Animals, Antirheumatic Agents, Arthritis, Rheumatoid, Disease Models, Animal, Drug Design, Humans, Mice, Rats